Private company
SANGUI BIOTECH INTERNATIONAL INC
SANGUI BIOTECH INTERNATIONAL INC is an American pharmaceutical preparations company based in Hamburg.2
Last updated Oct 21, 2026.
Overview
- IndustryPharmaceutical Preparations2
- HeadquartersHamburg, Germany2
- Incorporated inCO4
- Business address352 South 200 West, Suite 3, Farmington, Ut 840254
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formBusiness Corporation2
- LEI52990066GTW94YLZ2Z582
- StatusActive2
- LEI statusIssued and current2
- Registered addressc/o Corporation Service Company, 1900 W. Littleton Boulevard, 80120 Littleton, United States2
- Registered withBusiness Division of the Secretary of State’s office, 199510894532
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Research and development12¢$8.6K
- Other costs61¢$42.3K
- Interest27¢$18.3K
Out of $69.2K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $127.5K5 | $48.0K6 | $67.7K7 | $77.2K8 | $88.0K9 | $28.9K10 | $65.6K3 | $69.2K3 |
| Cost of revenue | $5325 | $2936 | $6937 | $628 | $08 | |||
| Gross profit | $126.9K5 | $47.7K6 | $67.0K7 | $77.1K8 | $88.0K9 | $28.9K10 | $65.6K3 | $69.2K3 |
| Research and development | $205.0K5 | $37.8K6 | $16.5K7 | $23.0K8 | $27.2K9 | $8.3K10 | $8.3K3 | $8.6K3 |
| Operating expenses | $208.6K3 | |||||||
| Operating income | -$360.9K6 | -$316.8K7 | -$208.0K8 | -$337.6K9 | -$181.4K10 | -$151.1K3 | -$139.4K3 | |
| Interest | -$6.1K5 | -$69.8K6 | -$9.2K7 | -$8.3K7 | $9.8K9 | $14.0K10 | $18.0K3 | $18.3K3 |
| Income tax | $08 | $09 | $010 | $03 | $03 | |||
| Net income | -$758.4K5 | -$446.4K6 | -$330.2K7 | -$201.8K8 | -$323.6K9 | -$192.7K10 | -$198.9K3 | -$59.3K3 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $17.7K6 | $70.1K7 | $57.0K8 | $20.9K9 | $27.5K10 | $15.3K3 | $29.8K3 | $30.5K3 |
| Receivables | $13.3K3 | |||||||
| Current assets | $72.1K5 | $110.4K6 | $93.8K7 | $102.0K8 | $79.0K9 | $48.7K10 | $66.7K3 | $67.7K3 |
| Property, plant and equipment | $3583 | |||||||
| Total assets | $122.1K5 | $110.4K6 | $93.8K7 | $102.0K8 | $79.0K9 | $125.3K10 | $134.1K3 | $130.8K3 |
| Short-term debt | $707.7K3 | |||||||
| Current liabilities | $461.9K14 | $358.0K6 | $354.3K7 | $453.2K8 | $671.0K9 | $791.5K10 | $954.7K3 | $935.6K3 |
| Long-term liabilities | $90.1K3 | |||||||
| Total liabilities | $671.0K9 | $855.2K10 | $1.0M3 | $1.0M3 | ||||
| Retained earnings | -$38.0M3 | |||||||
| Shareholders’ equity | -$339.8K5 | -$247.6K6 | -$260.5K7 | $271.1K8 | $49.2K9 | -$82.9K10 | -$223.5K3 | -$239.1K3 |
| Shares outstanding | 147.1M shares14 | 174.5M shares5 | 187.3M shares6 | 193.0M shares7 | 201.5M shares8 | 203.3M shares9 | 207.9M shares10 | 209.9M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare SANGUI BIOTECH INTERNATIONAL INC with another company
What it owns
What SANGUI BIOTECH INTERNATIONAL INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Leasehold improvements | $62.7K3 Jun 30, 2022 | $66.2K3 Jun 30, 2021 | −5.3% |
| Property and equipment, before depreciation | $2.9K3 Jun 30, 2022 | $3.3K3 Jun 30, 2021 | −11.5% |
| Property and equipment, net | $3583 Jun 30, 2022 | $1.2K3 Jun 30, 2021 | −70.5% |
Investments
Leadership
Who has led SANGUI BIOTECH INTERNATIONAL INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerThomas Striepe Aug 22, 2008 to Aug 12, 202215
- Chief executive officerWolfgang Barnikol May 22, 2007 to Apr 3, 200816
- PresidentThomas Striepe Aug 6, 2009 to Aug 12, 202217
- PresidentWolfgang Barnikol May 22, 2007 to Apr 3, 200816
- Chief financial officerThomas Striepe Oct 12, 2016 to Aug 12, 202218
- Chief financial officerWolfgang Barnikol Apr 3, 2008 to Apr 3, 200819
- Chief financial officerJoachim Fleing Aug 25, 2008 to Sep 9, 201520
Board members and other officers (5)
- Board memberHubertus Schmelz Sep 14, 2009 to Aug 12, 202221
- Board memberJoachim Fleing Apr 30, 2007 to Sep 9, 201522
- Board memberLutz Joachim Apr 30, 2007 to Aug 25, 200823
- Board memberThomas Striepe May 7, 2007 to Aug 12, 202224
- Board memberWolfgang Barnikol May 22, 2007 to Aug 25, 200816
Former names
- FELNAM INVESTMENTS INCJan 28, 2000 to Jan 28, 20004
Timeline
Filings
12 filings to the SEC since October 2021: 1 annual reports, 6 quarterly reports, 1 major events, 3 insider forms, 1 other. The latest 12:
- Jul 3, 2025REVOKED EDGAR
- May 12, 202310-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Feb 7, 202310-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Nov 10, 202210-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Nov 3, 20228-K EDGAR
- Sep 28, 202210-K SANGUI BIOTECH INTERNATIONAL INC - FORM 10-K SEC FILING EDGAR
- Aug 12, 20225 PRIMARY DOCUMENT EDGAR
- Aug 12, 20225 PRIMARY DOCUMENT EDGAR
- May 16, 202210-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Feb 11, 202210-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Nov 12, 202110-Q SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING EDGAR
- Oct 18, 20214 PRIMARY DOCUMENT EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 13, 2021 | Schmelz HubertusDirector | Sale | 1,200,000 | $0.02 | $24.0K | Form 4 |
From Forms 4 filed with the SEC.
SEC filer profile
How SANGUI BIOTECH INTERNATIONAL INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSANGUI BIOTECH INTERNATIONAL INC1
- CIK0001104280
- Employer ID (EIN)84-13307321
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inColorado1
- Fiscal year endsJune 301
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address352 South 200 West, Suite 3, Farmington, UT 840251
- Phone011 49 (40) 60931201
- Shares outstanding209,901,842 as of May 12, 202313
- Public float$1.9M as of Dec 31, 20213
- On EDGAR sinceJan 28, 20001
- Filings314 in all: 5 (53), 10-Q (45), 8-K (30), 10QSB (25), UPLOAD (19), 424B3 (18), 4 (17), NT 10-Q (17)1
All 30 form types
10-K (14), 3 (12), NT 10-K (11), CORRESP (10), 10KSB (9), 10QSB/A (5), 10-Q/A (4), 10KSB/A (4), 10-K/A (3), 4/A (3), 8-K/A (3), NTN 10K (2), 10SB12G (1), 3/A (1), DEF 14A (1), EFFECT (1), NTN 10Q (1), PRE 14A (1), REVOKED (1), S-1 (1), S-8 (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Sep 28, 2022
Quarterly report (10-Q) May 12, 2023
Proxy statement (DEF 14A) Oct 22, 2008
Latest 8-K (8-K) Nov 3, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARThomas Striepe, President
- 18
- 19
- 20
- 21SEC EDGARHubertus Schmelz, Board member
- 22SEC EDGARJoachim Fleing, Board member
- 23SEC EDGARLutz Joachim, Board member
- 24SEC EDGARThomas Striepe, Board member
- 25SEC EDGARListing notice or transfer